Telix Pharmaceuticals TLX
NASDAQ TLX
$10.55 -0.17 (-1.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Other Accumulated Expenses (2024 - 2025)

Updated

Telix Pharmaceuticals (TLX) posted Other Accumulated Expenses of $72.45 million for the quarter ended Dec 31, 2025, down 16.0% from $86.25 million a year earlier.

Analysis

Telix Pharmaceuticals (TLX) Other Accumulated Expenses (2024 - 2025) Analysis & Trends

  • In prior years, Telix Pharmaceuticals' Other Accumulated Expenses was $86.25 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Telix Pharmaceuticals 3.57 Bn 2.51 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 72.45 Mn
Dec 31, 2024 86.25 Mn
API Access

Telix Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TLX&period=max&api_key=YOUR_API_KEY